(R)-Nepicastat hydrochloride is a potent and selective inhibitor of dopamine-β-hydroxylase (DBH) in both bovine and human, with IC50 values of 25.1 nM and 18.3 nM, respectively; it exhibits minimal affinity for 12 other enzymes and 13 neurotransmitter receptors. It concentration-dependently inhibits dopamine-β-hydroxylase activity in vitro. In vivo, (R)-Nepicastat (30 mg/kg, oral) reduces norepinephrine levels, dopamine levels, and the dopamine/norepinephrine ratio in the mesenteric artery and left ventricle of spontaneously hypertensive rats (SHR).